Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $164.90 | Total: $824.50 |
| 1 | 10 | $139.68 | Total: $1,396.80 |
| 1 | 25 | $118.34 | Total: $2,958.50 |
| 1 | 50 | $100.88 | Total: $5,044.00 |
| 1 | 100 | $87.30 | Total: $8,730.00 |
Overview
Levolansoprazole ((S)-Lansoprazole), a proton pump inhibitor, irreversibly inhibits H+K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 ?M). It also inhibits acid formation in isolated canine parietal cells (IC50: 82 ?M). Both (R)- and (S)-lansoprazole are pharmacologically active with similar potencies.
Chemical Properties
| Molecular Formula | C16H14F3N3O2S |
| Molecular Weight | 369.36 |
| CAS Numbers | 138530-95-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | S(CC1=C(C)C(OCC(F)(F)F)=CC=N1)(=O)C=2NC=3C(N2)=CC=CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Gellad WF, Choi P, Mizah M, Good CB, Kesselheim AS. Assessing the chiral switch approval and use of single-enantiomer drugs, 2001 to 2011. Am J Manag Care. 2014 Mar 1;20[3] e90-7. PubMed PMID 24773330.